Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.96 |
| ▸ | LMNA | P02545 | 1/20 | 0.96 |
| ▸ | PRKCA | P17252 | 4/20 | 0.81 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.81 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.81 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.81 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.74 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.74 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.74 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.72 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9717938 | 0.98 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL896399 | 0.98 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL896443 | 0.98 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL24333834 | 0.98 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL23612380 | 0.98 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL24334742 | 0.98 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL24334040 | 0.98 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL24333843 | 0.98 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL22973398 | 0.98 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| Tripalmitin SCHEMBL2017107 | 0.98 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1478 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743533-A1 | SORBENTS FOR OIL-BASED FLUIDS | ALBEMARLE CORPORATION (US) | 2026-05-20 | — | — | EP | claimed |
| US-20260130395-A1 | Water Dispersible Botanical Compositions | AQUILA BLACK LTD (AU) | 2026-05-14 | — | — | US | claimed |
| EP-4734959-A1 | USE OF GLYCERIDES FOR LNP FORMULATIONS | Sanofi Pasteur Inc. (US) | 2026-05-06 | — | — | EP | claimed |
| EP-4658106-A1 | STABILIZED AEROSOL PRECURSOR FORMULATIONS | RAI Strategic Holdings, Inc. (US) | 2025-12-10 | — | — | EP | claimed |
| US-20250241899-A1 | Topical Antifungal Non-Aqueous Formulations and Preparation Methods Thereof | Hefei Cosource Pharmaceuticals Co., Ltd (CN) | 2025-07-31 | — | — | US | claimed |
| WO-2025151073-A1 | COMPOSITION AND NANOPARTICLE SUITABLE FOR USE IN THE DELIVERY OF A THERAPEUTIC AGENT | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2025-07-17 | — | — | WO | claimed |
| WO-2025120610-A1 | LIQUID/SOLID HYBRID MATERIALS AS STABILIZED BROMOFORM AND OTHER ANTI-METHANOGENIC FORMULATIONS FOR ADMINISTRATION TO RUMINANTS | Loam Bio Pty Ltd (AU) | 2025-06-12 | — | — | WO | claimed |
| US-20250144021-A1 | GEL FORMULATIONS FOR LOCAL DRUG RELEASE | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2025-05-08 | — | — | US | claimed |
| WO-2025083081-A1 | FAT COMPOSITION COMPRISING TRIBUTYRIN AND TRICAPROIN AND ITS USE IN MILK REPLACERS | NUTRECO IP ASSETS B.V. (NL) | 2025-04-24 | — | — | WO | claimed |
| WO-2025083077-A1 | FAT COMPOSITION COMPRISING TRIBUTYRIN AND ITS USE IN CALF MILK REPLACERS | NUTRECO IP ASSETS B.V. (NL) | 2025-04-24 | — | — | WO | claimed |
| US-5962016-A | A FAMILY OF MVL FORMULATIONS CONTAINING DIFFERENT SLOW:FAST RELEASE NEUTRAL LIPID MOLAR RATIOS DISPLAY DIFFERENT RELEASE RATES DEPENDING UPON THE MOLAR RATIO OF THE FAST RELEASE NEUTRAL LIPID TO THE SLOW RELEASE NEUTRAL LIPID IN EACH | DEPOTECH CORPORATION (US) | 1999-10-05 | — | — | US | claimed |
| US-5922331-A | PROTECTION AGAINST LUMPINESS, EDEMA AND OTHER EFFECTS FO LIPOSUCTION AND COSMETIC SURGERY | CHANEL, INC. (US) | 1999-07-13 | — | — | US | claimed |
| US-5891467-A | ENCAPSULATION AND RELEASE OF ACTIVE COMPOUNDS | DEPOTECH CORPORATION (US) | 1999-04-06 | — | — | US | claimed |
| US-5807572-A | FORMING OIL IN WATER EMULSION; DESOLVENTIZING | DEPOTECH CORPORATION (US) | 1998-09-15 | — | — | US | claimed |
| WO-1998033483-A1 | METHOD FOR UTILIZING NEUTRAL LIPIDS TO MODIFY IN VIVO RELEASE FROM MULTIVESICULAR LIPOSOMES | SKYEPHARMA, INC. (US) | 1998-08-06 | — | — | WO | claimed |
| US-5438041-A | Hemoglobin in vegetable oil, animal oil triglyceride and mixtures; emulsified; synthetic blood | ILLINOIS INSTITUTE OF TECHNOLOGY (US) | 1995-08-01 | — | — | US | claimed |
| US-5217648-A | In physiologically compatible oil | ILLINOIS INSTITUTE OF TECHNOLOGY (US) | 1993-06-08 | — | — | US | claimed |
| US-4479944-A | SOLVENT, CLATHRATE | ONO PHARMACEUTICAL CO., LTD. (JP) | 1984-10-30 | — | — | US | claimed |
| US-4172149-A | COATING WITH TRIGLYCERIDES | WESTWOOD PHARMACEUTICALS, INC. (US) | 1979-10-23 | — | — | US | claimed |
| US-3977945-A | Time and temperature-dependent enzymatic indicator | FOOD CONTROL AB (SW) | 1976-08-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260130395-A1 | Water Dispersible Botanical Compositions | TTPA, PNLIP, SRMS | ALDH1A1 2919/4885LMNA 1292/4885PRKCA 559/4885 |
| US-20250144021-A1 | GEL FORMULATIONS FOR LOCAL DRUG RELEASE | TREH, GALE, SLC2A8 | ALDH1A1 3664/4885LMNA 4434/4885PRKCA 2489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.